Citation Impact

Citing Papers

Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
2005 Standout
A Novel Germline Variant in CSF3R Reduces N-Glycosylation and Exerts Potent Oncogenic Effects in Leukemia
2018 StandoutNobel
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Evidence- and consensus-based practice guidelines for the therapy of primary myelodysplastic syndromes. A statement from the Italian Society of Hematology.
2002
ZMYND8 acetylation mediates HIF-dependent breast cancer progression and metastasis
2018
Birth Weight and Risk for Childhood Leukemia in Denmark, Sweden, Norway, and Iceland
2004
Down-Regulation of Na+/K+ATPase Activity by Human Parvovirus B19 Capsid Protein VP1
2013 Standout
Two types of acquired idiopathic sideroblastic anaemia (AISA)
1990
Cytogenetic, Molecular Genetic, and Clinical Characteristics of Acute Myeloid Leukemia With a Complex Karyotype
2008
Constitutional aneuploidy and cancer predisposition
2009
Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells,
2003
Constitutively activating mutation in WASP causes X-linked severe congenital neutropenia
2001
Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study
2009 Standout
RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
2011 StandoutNature
α-interferon in myelodysplasia; Clinical observations and effects on nk cells
1988
Cytogenetics in acute leukemia
2003
Single-Cell Profiling Identifies Aberrant STAT5 Activation in Myeloid Malignancies with Specific Clinical and Biologic Correlates
2008
Cushing's syndrome
2015 Standout
Molecular characterization of a peripheral receptor for cannabinoids
1993 StandoutNature
New insights into nNOS regulation of vascular homeostasis
2005 StandoutNobel
Mortality associated with Down's syndrome in the USA from 1983 to 1997: a population-based study
2002 Standout
Risks of leukaemia and solid tumours in individuals with Down's syndrome
2000
Osteoporosis: now and the future
2011 Standout
Dickkopf-1: a suitable target for the management of myeloma bone disease
2009
The molecular control of cell division, differentiation commitment and maturation in haemopoietic cells
1989 StandoutNature
Myelodysplasia with fibrosis: a distinct entity?
2001
Microarray-based classification of a consecutive series of 121 childhood acute leukemias: prediction of leukemic and genetic subtype as well as of minimal residual disease status
2007
A phase II study of intensive chemotherapy with fludarabine, cytarabine, and mitoxantrone in P glycoprotein-negative high-risk myelodysplastic syndromes
2004
Functions of natural killer cells
2008 Standout
WNT signaling in bone homeostasis and disease: from human mutations to treatments
2013 Standout
Effects of Recombinant Human Granulocyte–Macrophage Colony-Stimulating Factor in Patients with Myelodysplastic Syndromes
1987
Biology of Natural Killer Cells
1989 Standout
Induction of Apoptosis in HL-60 Human Promyelocytic Leukemia Cells by Adenosine A3Receptor Agonists
1996 StandoutNobel
The myelodysplastic syndrome.
1989
Guidelines for the diagnosis and therapy of adult myelodysplastic syndromes
2003
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
2005 Standout
Adipocyte tissue volume in bone marrow is increased with aging and in patients with osteoporosis
2001
Genetics of adrenal tumors associated with Cushing's syndrome: a new classification for bilateral adrenocortical hyperplasias
2007
Imaging Dynamic Redox Changes in Mammalian Cells with Green Fluorescent Protein Indicators
2004 StandoutNobel
Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone
2014 StandoutNature
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
2013 Standout
Virus target cell conditioning model to explain some epidemiologic characteristics of childhood leukemias and lymphomas
2005 StandoutNobel
Clinical and biological importance of cytogenetic abnormalities in childhood and adult acute lymphoblastic leukemia
2004
Down's syndrome
2003 Standout
Serologic Study on Parvovirus B19 Infection in Childhood Acute Lymphoblastic Leukemia During Chemotherapy: Clinical and Hematologic Implications
2002
Clinical manifestations of hematologic and oncologic disorders in patients with Down syndrome
2006
The Italian Consensus Conference on Diagnostic Criteria for Myelofibrosis with Myeloid Metaplasia
1999
Health Supervision for Children With Down Syndrome
2011 Standout
Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis
2012 Standout
Differentiation induction therapy of myelodysplastic syndromes
1989
PHD3 Loss in Cancer Enables Metabolic Reliance on Fatty Acid Oxidation via Deactivation of ACC2
2016 StandoutNobel
Parvovirus B19
2004 Standout
Nfe2l3 (Nrf3) deficiency predisposes mice to T-cell lymphoblastic lymphoma
2010
Role of Nrf2 in Oxidative Stress and Toxicity
2013 Standout
Characterization of the early lesion of 'degenerative' valvular aortic stenosis. Histological and immunohistochemical studies.
1994 Standout
Changes in trabecular bone, hematopoiesis and bone marrow vessels in aplastic anemia, primary osteoporosis, and old age: A comparative histomorphometric study
1987
Induction of Tumor Immunity by Removing CD25+CD4+ T Cells: A Common Basis Between Tumor Immunity and Autoimmunity
1999 StandoutNobel
5 Myelodysplastic syndromes
1987
Myeloperoxidase Deficiency
1988
Primary myelodysplastic syndromes: diagnostic and prognostic significance of immunohistochemical assessment of bone marrow biopsies
1992
Comparative Analysis of Mesenchymal Stem Cells from Bone Marrow, Umbilical Cord Blood, or Adipose Tissue
2006 Standout
Human Parvovirus B19
2002 Standout
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
2009 Standout
Antimicrobial polypeptides of human neutrophils
1990
Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification?
2006
Inhibiting Dickkopf-1 (Dkk1) Removes Suppression of Bone Formation and Prevents the Development of Osteolytic Bone Disease in Multiple Myeloma
2009
Human Dendritic Cells Activate Resting Natural Killer (NK) Cells and Are Recognized via the NKp30 Receptor by Activated NK Cells
2002 StandoutNobel
Longer metaphase and fewer chromosome segregation errors in modern human than Neanderthal brain development
2022 StandoutNobel
International Scoring System for Evaluating Prognosis in Myelodysplastic Syndromes
1997 Standout
The HL-60 promyelocytic leukemia cell line: proliferation, differentiation, and cellular oncogene expression
1987
Inhibiting Dickkopf-1 (Dkk1) Removes Suppression of Bone Formation and Prevents the Development of Osteolytic Bone Disease in Multiple Myeloma
2008
Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells.
1993 Standout
Mutations of the Wiskott-Aldrich Syndrome Protein (WASP): hotspots, effect on transcription, and translation and phenotype/genotype correlation
2004
Immunohistological Analysis of Human Lymphoma: Correlation of Histological and Immunological Categories
1984
Induction of differentiation-associated changes in established human cells by infection with adeno-associated virus type 2
1992 StandoutNobel
Single-Cell Mass Cytometry of Differential Immune and Drug Responses Across a Human Hematopoietic Continuum
2011 StandoutScience
Population-based age-specific incidences of cytogenetic subgroups of acute myeloid leukemia.
2005
From Estrogen-Centric to Aging and Oxidative Stress: A Revised Perspective of the Pathogenesis of Osteoporosis
2010 Standout
Evidence for nonclonal hematopoietic progenitor cell populations in bone marrow of patients with myelodysplastic syndromes
1994 StandoutNobel
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
2015 Standout
Methylation of hypoxia-inducible factor (HIF)-1α by G9a/GLP inhibits HIF-1 transcriptional activity and cell migration
2018 StandoutNobel
HOW NEUTROPHILS KILL MICROBES
2005 Standout
The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells
1985 Standout
Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps
2010 Standout
The World Health Organization (WHO) classification of the myeloid neoplasms
2002 Standout
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
2016 Standout
NATURAL KILLER CELLS IN ANTIVIRAL DEFENSE: Function and Regulation by Innate Cytokines
1999 Standout
LEF-1 is crucial for neutrophil granulocytopoiesis and its expression is severely reduced in congenital neutropenia
2006 Standout

Works of Gitte Kerndrup being referenced

Prognostic significance of some clinical, morphological and cytogenetic findings in refractory anaemia (RA) and RA with sideroblasts
1986
Natural killer (NK)-cell activity and antibody-dependent cellular cytotoxicity (ADCC) in primary preleukemic syndrome
1984
Late relapse of adrenocortical carcinoma in Beckwith‐Wiedemann syndrome. Clinical, endocrinological and genetic aspects
2003
Parvovirus B19 infection infrequently involved in children and adults with myelodysplastic syndrome
1996
Cytogenetic findings in adult de novo acute myeloid leukaemia. A population‐based study of 303/337 patients
2003
Acute leukemia cytogenetics
2001
Fusion of ZMYND8 and RELA Genes in Acute Erythroid Leukemia
2013
Contribution of multiparameter genetic analysis to the detection of genetic alterations in hematologic neoplasia. An evaluation of combining G-band analysis, spectral karyotyping, and multiplex reverse-transcription polymerase chain reaction (multiplex RT-PCR)
2006
Cytogenetic abnormalities in childhood acute myeloid leukaemia: a Nordic series comprising all children enrolled in the NOPHO‐93‐AML trial between 1993 and 2001
2003
Clinical and cytogenetic features of a population‐based consecutive series of 285 pediatric T‐cell acute lymphoblastic leukemias: Rare T‐cell receptor gene rearrangements are associated with poor outcome
2009
Myeloma cell expression of 10 candidate genes for osteolytic bone disease. Only overexpression of DKK1 correlates with clinical bone involvement at diagnosis
2007
A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases
2003
Prognostic impact of karyotypic findings in childhood acute lymphoblastic leukaemia: a Nordic series comparing two treatment periods
2000
Analysis of leucocyte differentiation antigens in blood and bone marrow in patients with refractory anaemia (RA) and RA with sideroblasts. Prognostic implications of sequential and follow‐up data
1988
Cytogenetic aberrations in adult acute lymphocytic leukemia
2001
Primary myelodysplastic syndrome: Treatment of 6 patients with 13‐cis retinoic acid
1986
Histomorphometrical Determination of Bone Marrow Cellularity in Iliac Crest Biopsies
1980
Childhood myelodysplastic syndrome in Denmark: incidence and predisposing conditions.
1995
Intensive chemotherapy in childhood myelodysplastic syndrome. A comparison with results in acute myeloid leukemia.
1996
Chronic parvovirus infection mimicking myelodysplastic syndrome in a child with subclinical immunodeficiency.
1994
13-cis Retinoic acid treatment of myelodysplastic syndromes
1987
Myeloperoxidase‐deficient polymorphonuclear leucocytes (VI): Relation to cytogenetic abnormalities in primary myelodysplastic syndromes
1986
A Clinicopathological Study of 13 Danish Cases of Burkitt's Lymphoma
1981
Myeloperoxidase‐deficient polymorphonuclear leucocytes (V): Relation to FAB‐classification and neutrophil alkaline phosphatase activity in primary myelodysplastic syndromes
1985
Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases. European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS)
1997
Mutation Spectrum in Patients with Wiskott-Aldrich Syndrome and X-linked Thrombocytopenia: Identification of Twelve Different Mutations in the WASP Gene
1996
Rankless by CCL
2026